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Regulation of immune responsiveness has been attributed theoretically (1, 2)  and 
experimentally (3, 4)  to interactions between idiotypic and anti-idiotypic structures. 
Constituents  of this  idiotype network  can  be  induced  and  triggered  without  the 
intervention of external antigens  (5-10).  For instance, anti-idiotypic antibodies can 
mimic  specific  antigen  to  promote  the  induction  (9,  10)  or  suppression  (5-7)  of 
synthesis of the idiotypic antibody in the absence of antigen. In general, low doses of 
anti-idiotypic  antibody  directly  induce  idiotype  or  facilitate  an  enhancement  of 
idiotype expression during subsequent  antigenic stimulation.  Higher doses of anti- 
idiotypic antibody promote suppression of idiotype expression (3,  11). 
In the antigen-specific response to the p-azobenzenearsonate (ABA) 1 hapten group, 
a  large proportion of the anti-ABA antibodies induced in A/J  mice share a  cross- 
reactive idiotype (CRI) (12) representing a nonidentical, but closely related, family of 
idiotypic determinants (13-16). Immunoregulation of this idiotype has been demon- 
strated by two approaches. First, anti-idiotypic antibodies have been passively admin- 
istered, resulting in the suppression of the level of CRI + antibodies (6, 17, 18) and the 
induction of idiotype-specific suppressor T  cells  (T~) (17-19).  Second, CRI ÷ serum 
antibodies  (20,  21)  or  CRI  +  hybridoma proteins  (HP)  (22)  covalently coupled  to 
syngeneic lymphocytes have been used to induce idiotype-specific Ts and depress both 
the  production  of CRI  +  antibodies  (20,  22)  and  delayed-type hypersensitivity to 
antigenic challenge (21).  With both approaches, the production of total circulating 
anti-ABA antibodies is not substantially altered (6,  17,  18, 20, 22). Most attempts to 
investigate  the  regulation  of idiotype expression have  involved the  creation  of an 
artificial network by the passive administration of anti-idiotypic antibody or of the 
idiotype in adjuvant.  However, in a  few cases idiotypic modulation has been dem- 
onstrated during the development of an antibody response to specific antigen (8,  11, 
23, 24). 
In this paper, an attempt was made to investigate the regulation of idiotype by an 
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existing idiotype-anti-idiotype equilibrium  through the induction of tolerance in the 
anti-idiotypic  antibody response.  Unresponsiveness  was  induced  in anti-CRI  +  anti- 
body-producing cells using the HP from the anti-ABA monoclonal hybridoma R 16.7, 
a homogeneous representative of the family of CRI  + antibodies possessing one or more 
idiotypes common to all  CRI  + serum  antibodies  (14,  25).  Tolerance  induction  was 
accomplished in a manner previously demonstrated to establish a  functional deletion 
in T  and B cells specific for immunoglobulin antigen (26, 27). This type of unrespon- 
siveness has been demonstrated to be independent of antigen-specific suppressor cells 
(28,  29).  Mice  tolerized  to  this  idiotype  produce  little  circulating  anti-idiotypic 
antibody when challenged with either the antigen (ABA) or the idiotype (R 16.7 HP). 
Unresponsiveness  persists  when  tolerant  spleen  cells  are  transferred  into  irradiated 
recipients.  Homeostatic regulation  of idiotype expression  is relaxed  in unresponsive 
mice  not  producing  anti-idiotypic  antibody,  although  the  level  of total  anti-ABA 
antibody is uneffected. 
Materials  and Methods 
Mice.  Male A/J and CAF1 mice were obtained from The Jackson Laboratory, Bar Harbor, 
ME, at 4-5 wk of age. They were maintained ad lib on Wayne Lab Blox F6 (Allied Mills,  Inc., 
Chicago, IL) in chlorinated water acidified to pH 3.0. 
Monoclonal Idiotype + Anti-ABA  Antibodies.  The hybridoma cell line R16.7 secreting an IgGa 
immunoglobulin reactive to the ABA group was produced and characterized as described by 
Lamoyi et  al.  (14) and  obtained  through  the  generosity of Dr.  Alfred  Nisonoff,  Brandeis 
University,  Waltham,  MA.  Cells  were  maintained  in  Dulbecco's modified  Eagle's medium 
(Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) supplemented with 20% 
fetal  bovine serum  (Microbiological Associates,  Walkersville,  MD),  gentamycin  (50 /zg/ml) 
(Schering Corp., Kenilworth, N  J), glutamine, nonessential amino acids, and sodium pyruvate. 
Ascites fluid containing large amounts of antibody was produced by injecting 1-5 ×  106 cells 
into Pristane-primed CAF1 mice (30). The monoclonal R16.7 anti-ABA HP was purified by 
affinity chromatography on Sepharose 4B (Pharmacia Fine Chemicals, Pharmacia Inc., Pisca- 
taway,  N  J)  to which ABA-bovine serum  albumin  (BSA)  had  been conjugated as described 
elsewhere  (14). 
Antigens  and Immunizations.  ABA was conjugated to  BSA or keyhole limpet  hemoeyanin 
(KLH) by procedures previously described by Nisonoff (31). To elicit  primary responses to 
ABA, A/J mice were immunized intraperitoneally with 100/zg ABA-KLH in complete Freund's 
adjuvant (CFA).  For secondary responses,  mice received 400/zg ABA-KLH in alum intraperi- 
toneally. Immunization of mice with R16.7 was accomplished by intraperitoneal  injection of 
400/~g R16.7 HP incorporated in CFA. The injected volume in all cases was 0.2 ml. 
Anti-Idiotypic Antisera: Preparation and Assay.  Anti-idiotypic antisera were prepared in rabbits 
by injecting specifically purified R16.7 HP in CFA. The antisera were adsorbed by passage 
twice over columns of Sepharose 4B to which a crude globulin fraction of normal A/J mouse 
serum had been conjugated. All precipitating activity against normal mouse immunoglobulin 
was lost after a single passage.  Anti-Rl6.7 idiotype antibodies were further affinity-purified by 
elution from a R16.7 HP-eoupled Sepharose 4B column. Anti-idiotypic activity was determined 
in  the  presence of an  excess  of A/J  immunoglobulin,  i.e.,  20-25 /~1  of normal  A/J serum. 
Binding tests  were performed as described by Lamoyi et  al.  (14) with  10 ng of x25I-labeled 
R 16.7 HP as ligand and sufficient ant i-idiotypic antibody to bind 50-70% of  the ligand. Normal 
rabbit serum was added as a carrier and immune complexes were precipitated  with a slight 
excess of goat anti-rabbit Fc (N. L. Cappel Laboratories Inc., Cochranville, PA). All proteins 
were radiolabeled by modification of the ehlorimine-T method of protein iodination (32). 
Anti-ABA  Determination.  Anti-ABA antibody titers were measured by solid phase radioim- 
munoassay (RIA) using ABA-BSA-coated polyvinyl microtiter plates  (33).  Residual protein- 
binding capacity of the plates was saturated with BSA. Reagents used in all RIA were diluted 
in PBS containing 1% BSA and 0.05% Tween-20. Plates were washed and 100/~1 of 125I-labeled, 900  DEREGULATION OF IDIOTYPE  EXPRESSION 
purified goat anti-mouse Fab (N. L. Cappel Laboratories Inc.) was added to each well before 
overnight incubation, washing, and counting. 
Idiotype Determination.  Anti-ABA antibodies cross-reactive with the R16.7 idiotype used as a 
prototype of CRI were also quantitated with ABA-BSA-coated plates. After addition of 50-#1 
aliquots of experimental serum dilutions and subsequent washing, 100/~1 of rabbit anti-R16.7 
was added and incubated for 4 h at room temperature. After washing the plates, 100/~1 of 12~I- 
goat anti-rabbit Ig was added to each well and incubated overnight. The plates were washed 
before counting individual wells. 
Anti-ldiotype  Determination.  Anti-idiotypic antibody was quantitated  by coating polyvinyl 
microtiter plates with F(ab')2 R16.7  HP. Idiotype-coated plates were also blocked with BSA 
before addition of 50-#1 aliquots of antisera to individual wells and incubation for 4 h at room 
temperature. After washing, 100 #1 of 125I-goat anti-mouse Fc antibody (N. L. Cappel Labora- 
tories Inc.) was added to each well, incubated overnight, washed, and counted. 
F(ab')2  R16.7  HP Preparation.  To  obtain  a  F(ab')2 fragment  from  the  R16.7  idiotype  + 
immunoglobulin, the latter was  treated with  pepsin as described by  Spiegelberg (34).  The 
digested material was purified by passage through a Sepharose 4B column to which goat anti- 
mouse Fe IgG had been conjugated. This column eliminated Fc fragments as well as undigested 
immunoglobulin.  The  F(ab')2 fragment  effluent  was  bound  to  ABA-BSA coated  plates as 
described above. 
Tolerance Induction to the R16.7 Idiotype.  Tolerance to the R16.7  idiotype was attempted by 
intraperitoneal injection of the affinity-purified HP from R16.7 cells. When desired, the R16.7 
HP was depleted of aggregates by uhraeentrifugation at 150,000 g for 2.5 h  (28). Treated mice 
were subsequently injected with either ABA-KLH in CFA and alum or R16.7 HP in CFA and 
bled at various times as indicated. 
Adoptive Cell Transfer.  For adoptive transfer experiments, a cell suspension from the spleens 
of tolerant or control mice was obtained (35). Lethally irradiated (900 rad) mice were injected 
with  7  ×  107  spleen  cells  i.v.  Reconstituted  mice  were  immediately immunized  with  the 
appropriate antigen and bled at various times thereafter. 
Half-Life Determinations of R16. 7 HP.  Q~uantitation of the half-life of R16.7 HP in A/J mice 
was performed by two methods. 200 #g of 25I-labeled R16.7 HP (sp act 3 #Ci/#g) were injected 
intraperitoneally, and the amounts of gamma radiation in both the blood and the whole body 
were measured at different time intervals. The half-life of injected HP was also determined in 
serum at various times after inoculation with 1 mg R16.7 HP by the solid phase RIA described 
above. 
Results 
In  Vivo  Catabolism  of R16.7  Idiotype.  Two  experimental  protocols  were  used  to 
determine the rate of disappearance of the R16.7  HP from A/J mice after injection. 
First, the 125I activity retained in both the whole body and the blood of mice injected 
with 200/~g of x25I-labeled R16.7 HP was followed for 9 d. The results of whole body 
counts shown in panel A  of Fig.  1 demonstrate that 50% of the HP was catabolized 
every 7.7 d. The persistance of TCA-percipatable counts in the blood of these animals, 
panel B of Fig. 1, indicated a very similar rate of elimination. The difference between 
the amount of radiolabeled R16.7  HP per ml of blood and the amount  in the whole 
body suggests that, when administered passively, this immunoglobulin is distributed 
in equivalent proportions in intra- and extravascular fluid spaces. Similar rates and 
proportions  have  previously  been  reported  for  undenatured  immunoglobulins  in 
rabbits and mice  (36,  37).  These data indicate that  this monoclonal murine  immu- 
noglobulin is catabolized at a  normal rate and that all lymphoid cells are potentially 
exposed to the R16.7  idiotype. 
Second, RIA determinations of R 16.7 idiotype in the serum of mice receiving 1 mg 
of unlabeled R16.7  HP were also performed. Fig. 2  illustrates one such experiment. 
7 d after injection, serum analysis indicated a mean of 106.3 #g/ml of R 16.7 idiotype  + L.  ORTIZ-ORTIZ,  W.  O.  WEIGLE,  AND  D.  E.  PARKS  901 
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Fzc.  1.  In vivo catabolism of t~I-R16.7 HP in A/J mice. The rate of disappearance of 200/.tg of 
soluble ~2~I-labeled R16.7  HP injected intraperitoneally was monitored by quantitating the  12sI 
activity in the whole body (panel A) and in the blood (panel B). The mean of five mice per group 
is presented. 
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FIG:  2.  Detection of passively administered R16.7 idiotype in serum by RIA. The concentration 
of circulating R16.7  idiotype was  determined as  described in Materials and Methods after the 
injection of 1.0 mg soluble R16.7 HP i.p. The mean plus 1 SE of three or four mice per group are 
presented. Theoretical, expected values were obtained from the rate of 12sI disappearance found in 
Fig.  I. 
immunoglobulin.  The  amount  of R16.7  idiotype expected  from  Fig.  1 is  110/zg/ml. 
After  14 and  21  d, the sera contained  46.8 and  21.0/tg/ml  of R  16.7 idiotype by RIA, 
whereas  the theoretical  values obtained  from  the rate of 125I disappearance  in Fig.  I 902  DEREGULATION  OF IDIOTYPE EXPRESSION 
are 50.7 and 23.4/.~g/ml, respectively. The experiments described here correlate with 
a  half-life of 7.6 d  for the R16.7  HP in serum  and confirm that  the  RIA for R16.7 
idiotype accurately quantitates  this idiotype in circulation. 
Induction  of Immunologic  Unresponsiveness to  the  R16.7  Idiotype.  Experiments  were 
performed to determine the ability to induce unresponsiveness in cells producing anti- 
idiotypic antibody by inoculating A/J  mice with  R16.7  idiotype.  For this  purpose, 
animals  were injected  intraperitoneally  with  increasing  doses of R16.7  HP ranging 
from 0.1  to 2.0 rag. The affinity-purified, monoclonal immunoglobulin was deaggre- 
gated  immediately before injection.  18  d  after treatment,  the mice were challenged 
with  400  /zg  of R16.7  HP  incorporated  in  CFA.  Fig.  3  illustrates  the  degree  of 
responsiveness  to  the  idiotype  as  monitored  by  anti-R16.7  idiotype  antibody  in 
circulation  using  the  RIA  described  in  Materials  and  Methods.  In  contrast  to 
untreated  mice  (group  1)  mice inoculated  previously with  deaggregated  R16.7  HP 
(groups 2-5) produced no detectable anti-idiotypic responses 7 d after challenge with 
the idiotype in CFA.  14 d  after challenge, only marginal  responses were observed in 
tolerized mice. No differences could be detected in the hyporesponsiveness of animals 
given 500/zg or more of deaggregated R16.7 HP, with a  maximum mean response of 
15%  of control  values.  These  data  demonstrate  that  it  is  possible  to  substantially 
restrict responsiveness to the R16.7 idiotype by prior injection of a tolerogenic dose of 
monoclonal immunoglobulin bearing the idiotype. 
Duration of Unresponsiveness to the R16. 7 Idiotype.  Studies were undertaken  to deter- 
mine the duration  of the unresponsive state induced to the R16.7  idiotype.  For this 
purpose, mice were rendered  unresponsive to the idiotype with a  single,  tolerogenic 
injection of 1.0 mg soluble R16.7 HP and were challenged at different intervals with 
immunogenic R16.7  HP in CFA.  As illustrated  in Fig.  4, tolerized mice challenged 
after  18 d  (group 2)  responded  very poorly, if at  all, either  7 or  14 d  after antigenic 
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FIG. 3.  Induction of immunologic unresponsiveness in the anti-idiotypic response with varying 
doses of R16.7 idiotype. 18 d after attempted tolerization with 0.1-2.0 mg deaggregated R 16.7 HP 
i.p. mice were challenged with 400/xg R16.7 HP in CFA i.p. (groups 2-5). The concentration of 
circulating antibody to the R16.7 idiotype was determined 7 and  14 d after antigenic challenge as 
described in Materials and Methods. All results are compared with the control response of untreated 
mice 14 d after challenge (group 1). The mean plus 1 SE of four to six mice per group are presented. 
n.d., not done. Group 
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FIG. 4.  Persistence of unresponsiveness to the R16.7 idiotype. The concentration  of circulating 
antibody to the R16.7 idiotype was assessed by challenge with 400 #g of R16.7 HP in CFA i.p. 18 
or 31  d after the induction of unresponsiveness with a single intraperitoneal  injection of 1.0 mg 
soluble R16.7 HP.  7 and  14  d  after  antigenic  challenge,  determinations  of the  anti-idiotypic 
antibody were made. The results of tolerized mice (groups 2 and 4) are compared with the control 
responses of untreated mice. The mean plus 1 SE of three to five mice per group are presented. 
challenge. In comparison, mice challenged 31 d after the induction of unresponsiveness 
(group  4)  did mount  a  slight  anti-idiotypic response.  However,  the  mean  response 
observed in these tolerized mice (group 4) was only 16% of untreated controls (group 
3) even when assayed 45 d  after tolerization. The responses of all tolerized groups are 
significantly  different  (P  <  0.001)  from  their  respective  control  groups.  Thus,  it 
appears that although the unresponsive state induced to this idiotype diminishes with 
time, profound unresponsiveness persists for more than a  month after tolerization. 
Prirnmy and Secondary Anti-ABA  Responses in  Idiotype Unresponsive Mice.  Anti-ABA 
responses were  determined  in  A/J  mice unresponsive  to  this  CRI +  R16.7  idiotype. 
Primary antibody responses to ABA were quantitated in sera of tolerized mice  14  d 
after immunization with  100 #g ABA-KLH  in CFA. Similarly, secondary antibody 
responses to the ABA group were measured in the sera obtained from the same mice 
4  d  after a  secondary injection of 400/~g ABA-KLH  in  alum.  Fig. 5  represents the 
data obtained after both primary and secondary immunizations.  The proportion of 
the total antibody produced to ABA determinants reactive with the rabbit anti-R16.7 
idiotype  antibodies  was  64%  and  59%,  respectively,  after  primary  or  secondary 
immunization of normal mice with ABA-KLH. These results are in agreement with 
previously published percentages of CRI  + anti-ABA antibodies in A/J mice (12, 38). 
In  contrast,  the  anti-ABA antibodies in  circulation of tolerized mice  are  almost 
exclusively R16.7  idiotype  +  (96%)  after  a  single  immunization  with  ABA-KLH  in 
CFA. After a  second immunization with ABA-KLH, tolerized mice start to produce 
idiotype-  anti-ABA  antibodies,  but  the  percent  of  idiotype  +  antibodies  remains 
significantly higher (79% in group 2)  than  in normal, control mice (59%  in group  1) 
P  <  0.01.  The  amount  of total  anti-ABA  antibody  was  the  same  in  normal  and 
tolerized  mice  after  primary  challenge  with  ABA-KLH  and  slightly  increased  in 
normal mice after a secondary antigenic challenge. These data indicate that regulation 
of anti-ABA antibodies possessing the R16.7 idiotype is relaxed in mice unresponsive 
to this idiotype. However, the regulation of total antibody appears unaffected. 
Adoptive  Transfer of Unresponsiveness to  the  R16. 7 Idiotype.  Spleen  cells  from  mice 904  DEREGULATION OF IDIOTYPE  EXPRESSION 
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Fxe. 5.  Anti-ABA  antibody responses in mice unresponsive  to the R16.7 idiotype. The concentra- 
tions of total anti-ABA antibodies and R16.7 idiotype  + anti-ABA antibodies were determined by 
solid-phase RIA as described in Materials and Methods. Mice were rendered unresponsive to the 
R16.7 idiotype by a single  intraperitoneal injection of 1.0 mg soluble R16.7 HP. 18 d later, tolerized 
(group 2) and normal (group 1) mice received a primary injection of 100/,tg ABA-KLH in CFA i.p. 
14 d later, all mice were bled and their sera assayed. 4 h after bleeding, these mice were given a 
secondary challenge with 400 #g ABA-KLH in alum i.p., and they were bled again 4 d later. The 
means of the percentage of total ant  i-ABA antibody bearing the R 16.7 idiotype in individual mice 
are indicated. The mean plus l SE of three or four mice per group are presented. 
tolerized with R16.7 HP were transferred into lethally irradiated, normal recipients 
to remove persistent idiotype from  the environment of the  unresponsive cells. This 
procedure precluded the possible modulation of immune responsiveness or interference 
with  serological  determinations  by  passively  administered  R16.7  HP.  Irradiated 
recipients were reconstituted by 7 X  107 viable spleen cells from normal or tolerized 
mice. One-half of these recipients were immunized within 1 h with 100 #g ABA-KLH 
in CFA,  challenged  10  d  later  with  400  ~g  ABA-KLH  in  alum,  and  assayed  for 
circulating anti-ABA antibody 5 d  after secondary challenge. The data illustrated in 
Fig. 6 demonstrate that recipients of cells from tolerized mice (group 2 A)  produced 
slightly more anti-ABA antibody than did recipients of normal cells. However, both 
the  amount and  percent  of anti-ABA antibodies that  cross-reacts  with  the  R16.7 
idiotype were significantly higher (P <  0.001)  in recipients of tolerized cells. 
The other half of the reconstituted recipients were challenged with 400/~g R 16.7 
HP  in  CFA  to  assess  the  anti-idiotypic responsiveness of transferred  cells.  Fig.  6 
illustrates that cells from mice tolerized to the R16.7 idiotype remain unresponsive to 
the idiotype after transfer. Therefore, unresponsiveness  experimentally induced to the 
R16.7 idiotype is stable to adoptive transfer and cellular in nature. The observations 
that cells from mice unresponsive to the R16.7 idiotype respond in the reconstituted 
recipients as they do in the tolerized donor, both with respect to idiotype  + anti-ABA 
and anti-idiotypic antibodies, confirm that the effects reported herein are the result 
of modulation of the idiotype-anti-idiotype  network, not passively administered R 16.7 
HP. 
Interference with Induction of Unresponsiveness to the Idiotype by Antigen.  To determine 
the  possible effect  of antigen priming on  the  induction of unresponsiveness to  the 
R16.7  idiotype,  the  hapten  ABA was  injected on  the  immunogenic carrier  KLH 
before or during tolerization. 100 ~g ABA-KLH was injected either at the same time 
as, or 2  mo before,  1.0  mg soluble R16.7  HP.  Both  groups plus control groups not Group 
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Fza. 6.  Anti-ABA and anti-idiotypic antibodies of mice reconstituted  with cells unresponsive to 
the  R16.7 idiotype.  The concentration  of total anti-ABA,  R16.7 idiotype  +,  and  anti-idiotypic 
antibodies were determined  in lethally irradiated, syngeneic recipients reconstituted  with 7 X 107 
spleen cells from normal donors or donors tolerized 18 d previously with 1.0 mg soluble R16.7 HP 
i.p. Some recipients  (groups  1  A and 2A)  were immunized  intraperitoneally within  1 h of cell 
transfer with 100/lg ABA-KLH in CFA and 10 d later with 400/lg ABA-KLH in alum, and bled 
15  d  after  reconstitution.  The means of the percent  of total anti-ABA antibody that  is R16.7 
idiotype  + in individual mice is indicated.  Other recipients (groups 1  B and 2 B) were immunized 
within  1 h of cell transfer with 400/~g R16.7 HP in CFA and bled 14 d later. All groups contained 
five mice each except group 1  B, which contained three mice. The mean plus 1 SE are presented. 
given ABA-KLH or the tolerogen were later challenged twice with ABA-KLH in CFA 
and alum. The results of one such experiment are presented in Fig. 7. Antigen priming 
with  ABA at  the  time  of tolerization does  not  interfere with  the  establishment  of 
unresponsiveness to the idiotype as demonstrated by the lack of anti-idiotypic antibody 
in  circulation  (group  3).  In  contrast,  mice primed to ABA 2  mo  before attempted 
tolerization with  R16.7  HP  (group 4)  had  levels of anti-idiotypic antibody in their 
circulation indistinguishable from those of untreated control mice (group  1). Because 
none of the mice received R16.7  HP in the immunogenic form in CFA, the detected 
anti-idiotypic antibody  was  a  consequence  of immunization  to  the  antigen  ABA- 
KLH. 
When the response to specific antigen challenge was examined, the levels of anti- 
ABA  antibodies  cross-reacting  with  the  R16.7  idiotype  were  significantly  higher 
(P <  0.02)  in both the unresponsive groups (2 and 3) than in either of the groups  (1 
and 4)  responsive to the idiotype. In previously primed mice in which the induction 
of unresponsiveness  was  abrogated  (group  4),  the  percent  of R16.7  idiotype  +  anti- 
ABA antibody was  similar to  that  of normal  mice,  60%  and  66%,  respectively. In 
contrast,  in  successfully  tolerized  mice  not  possessing  detectable  circulating  anti- 
idiotypic  antibodies,  the  anti-ABA  antibodies  secreted  after  secondary  antigenic 
challenge are predominantly of the R16.7  idiotype, 88% and 83% for groups 2 and 3, 
respectively. These  data  indicate  that  unresponsiveness  cannot  be  induced  to  this 
idiotype in mice previously primed to the specific antigen. However, prior stimulation 
of idiotype  + anti-ABA antibody-producing cells, not the presence of antigen, appears 906 
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FIG.  7.  Interference with the induction of unresponsiveness  to idiotype by the antigen.  Mice were 
injected with  I00 p.g ABA-KLH  in CFA i.p. 2 mo before (group 4) or at the same time as (group 3) 
tolerization  with  1.0  mg  soluble  R16.7  HP.  18  d  after attempted  tolerance  induction,  all  groups 
were immunized with  100/~g ABA-KLH in CFA.  10 d later another injection of 400/~g  ABA-KLH 
in alum was given. Concentrations of circulating total anti-ABA R 16.7 idiotype + and anti-idiotypic 
antibodies  were assessed  4 d  after antigenic  challenge  in alum.  The  means  of the percent  of total 
anti-ABA antibody that bears the R16.7  idiotype  in individual  mice are indicated.  The mean plus 
1 SE of three to five mice per group are presented. 
to be responsible for this interference. 
Discussion 
The studies presented herein document the feasibility of inducing tolerance in an 
anti-idiotypic antibody response by the administration of excess idiotype. The role of 
idiotype-specific cells and antibody in the regulation of total and idiotype  + antibody 
are then assessed by virtue of the lesion created in the idiotype-anti-idiotype network 
following tolerization. This approach allows the examination of an existing network, 
not a network created or expanded by experimental  manipulation. 
Unresponsiveness was successfully induced in the anti-idiotypic antibody response 
by a  single injection of monoclonal R16.7  immunoglobulin possessing conserved or 
public idiotypic determinants common to the closely related, but not identical, family 
of CRI + anti-ABA antibody molecules  (14, 25). Tolerized mice were severely compro- 
mised in their ability to secrete circulating anti-idiotypic antibodies upon challenge 
with  the  R16.7  idiotype  incorporated  in  CFA.  This  unresponsive  state  was  stable 
upon  adoptive  cell  transfer  into  irradiated  syngeneic  recipients,  suggesting  that 
unresponsiveness  is  not  the  consequence  of passive  inhibition  by  excess  idiotype. 
Functional deletion in idiotype-specific B lymphocytes may have been accomplished 
as previously demonstrated during tolerization to other immunoglobulin antigens (26, 
27,  39).  Although  the  induction  of tolerance  to  immunoglobulin  antigens  can  be 
accomplished  in the absence of antigen-specific  suppressor cells  (28,  29, 40, 41),  the 
presence and role of suppressor cells specific for the anti-idiotypic antibody-producing 
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-bearing Ts have been described after the injection of anti-CRI + antibodies  (17,  18, 
19) or CRI  + antibody coupled to syngeneic lymphocytes (20, 21). In the present work, 
anti-idiotypic Ts do not appear to predominate in tolerized animals because CRI  + 
antibodies are elevated, not suppressed. However, the potential presence and contri- 
bution of anti-idiotype-specific T~ remains to be documented in  this unresponsive 
state. 
Tolerization of anti-idiotypic antibody-producing cells and the resulting reduction 
of circulating anti-R16.7 idiotype antibodies have profound effects on the regulation 
of idiotype expression. Deregulation of the idiotype produced upon challenge with 
the antigen ABA-KLH is observed in mice tolerized to the idiotype. Both the total 
amount and the percent of R 16.7 idiotype  + anti-ABA antibodies are increased during 
primary and  secondary responses  in  tolerized mice.  These  findings  unequivocally 
demonstrate that the expression of this idiotype is normally regulated by anti-idiotypic 
antibody or cells. In comparison, previous work has documented that CRI  + antibodies 
could be regulated experimentally with passively administered anti-idiotypic antibody 
(6,  17),  or T~  (17,  20), but  left unresolved the question of whether this regulation 
occurs as a normal consequence of specific antigen responsiveness. 
Elevation in the level of circulating idiotype  ÷ anti-ABA antibody after immuniza- 
tion of ABA-KLH can not be attributed to residual R 16.7 H P remaining in circulation 
after tolerization. Injection of antigen would  accelerate the clearance of tolerogen 
from circulation and  adoptive transfer of cells from tolerized animals  into normal 
recipients would remove all but cell-bound idiotype. Because low concentrations of 
passively administered anti-idiotypic antibody have been reported to stimulate  the 
expression of idiotype (9-11), the possibility exists that  the elevation of anti-R16.7 
idiotype  + antibodies in tolerized animals may not simply represent a lack of inhibition 
by anti-idiotype. Some of the tolerized mice continued to produce low levels of anti- 
R 16.7 idiotype antibody, which may stimulate the production of idiotype  + antibodies. 
However, correlation between  the  amount  of anti-idiotypic  antibodies  and  R16.7 
idiotype  + antibodies  in  individual  tolerized mice was  not  obvious in these studies. 
Another explanation for the predominance of R16.7 + antibody production in cells 
tolerant to this idiotype would be the presence of idiotype-specifie helper T  cells. 
The level of total anti-ABA antibodies was  substantially  uneffected by elevated 
idiotype expression resulting from deregulation of R16.7 idiotype  + B cells. In agree- 
ment with other approaches to experimental manipulation of idiotype expression (6, 
7, 18, 20, 22), these findings confirm that homeostatic mechanisms other than idiotype- 
anti-idiotype equilibria are ultimately responsible for the regulation of the level of 
total antibody production. The observed maintenance of total antibody levels in the 
face of increased idiotype expression reveals that  the synthesis of R16.7  idiotype- 
antibodies was selectively compromised in tolerized cells. This regulation of idiotype- 
antibody production may be a  passive consequence of the expansion of deregulated 
idiotype  +  B  cells  or  the  result  of an  active  process  similar  to  indirect  idiotype 
suppression (42). 
The  observations  reported  here  indicate  that  a  network  of idiotypic  and  anti- 
idiotypic regulatory elements are normally present  in the absence of overt antigen 
stimulation and can be perturbed without introducing antigen or idiotype in immu- 
nogenic form. Furthermore, compromise of a portion of this pre-existing network by 
tolerization with  idiotype in  a  nonimmunogenic form has profound effects on  the 908  DEREGULATION OF  IDIOTYPE  EXPRESSION 
components of the network in the absence of challenge with antigen (Figs. 3 and 4) or 
with the idiotype in CFA (Fig.  7). 
Although prior exposure to antigen interfered with the induction of tolerance in 
idiotype-specific cells, the co-injection of ABA-KLH and tolerogenic R 16.7 idiotype 
has no effect on induction of unresponsiveness. These data suggest that antigen alone 
does not influence the process of tolerance induction to the idiotype. It is more likely 
that the production of idiotypic and anti-idiotypic antibodies after antigen exposure 
modifies a subsequent tolerogenic signal to render it void or immunogenic. Although 
the induction of unresponsiveness to immunoglobulin antigens can be accomplished 
in previously activated B cells under certain conditions (43-45), mature, activated B 
lymphocytes are generally refractory to tolerance induction (43, 44, 46). This predis- 
position  to  activation  would  explain  why  tolerance  to  idiotypes,  which  are  self 
antigens, would not be naturally established nor maintained. Low levels of circulating 
idiotype may activate anti-idiotypic cells precluding tolerization. 
Documentation that tolerance to idiotype can be established experimentally pro- 
vides a  useful tool for the dissection of idiotype-anti-idiotype interactions and  their 
role in the regulation of immune function. The modulation of immune responsiveness, 
which results from tolerization to idiotype, also provides a  mechanism by which the 
subsequent  production of that  idiotype can  be  enhanced.  In  comparison  to  prior 
priming with antigen, which can mediate a  decrease in the expression of a  specific 
idiotype (47),  tolerization with the idiotype appears to be more efficient in selecting 
for an antigen response enriched for that idiotype. Although the effects of tolerization 
upon  network regulation  have  been  addressed  here,  little evidence on the  role of 
idiotypic networks in the induction and maintenance of tolerance has been forthcom- 
ing. Questions as  to whether or not  tolerance to antigen can be established  in  the 
presence of  a compromised network lacking specific components remain to be resolved. 
Summary 
The induction of tolerance in an anti-idiotypic response was attempted by in vivo 
exposure to excess idiotype.  Monoclonal  immunoglobulin  from  the  anti-p-azoben- 
zenearsonate (ABA)  hybridoma R16.7 was used as a representative of cross-reactive 
idiotype-positive (CRI +) antibodies because this hybridoma protein (HP) shares one 
or more closely related public idiotypic determinants with  the serum  CRI  in A/J 
mice. Immunologic unresponsiveness was established by a single injection of the R 16.7 
idiotype  and  persisted  for  at  least  6  wk.  The  level  of circulating  anti-idiotypic 
antibodies  in  tolerized  A/J  mice  was  significantly  depressed  after  immunogenic 
challenge  with  either  antigen,  ABA-keyhole  limpet  hemocyanin  (KLH),  or  the 
idiotype R 16.7 HP. Experimental depletion of  anti-idiotypic antibodies by tolerization 
allowed assessment  of immunoregulation  within  this  altered  idiotype-anti-idiotype 
network. Deregulation of idiotype expression in tolerized mice challenged with ABA- 
KLH was manifest with up to 96% of the anti-ABA antibodies cross-reacting with the 
R16.7  idiotype. This selective enhancement of a  major idiotype was  accomplished 
without substantial  alteration of the level of the overall anti-hapten response. Both 
the unresponsiveness established  in anti-idiotypic antibody-producing cells and  the 
enhanced synthesis in idiotype-producing cells were stable upon adoptive transfer into 
lethally  irradiated,  syngeneic recipients.  Finally,  previous  immunization  with  the 
antigen ABA-KLH interfered with the induction of unresponsiveness to the idiotype. L. ORTIZ-ORTIZ, W. O.  WEIGLE, AND D.  E.  PARKS  909 
This  interference  is  presumed  to be  mediated  by prior  activation  of anti-idiotypic 
cells and/or antibody because injection of antigen with tolerogenic idiotype did not 
abrogate tolerance induction. 
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